Skip to content

Tech-TYA: eHealth Platform to Deliver Group Intervention for YA Cancer Survivors

Adapting and Testing an eHealth Platform to Deliver a Group Intervention for Young Adult Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05597228
Enrollment
7
Registered
2022-10-28
Start date
2022-06-09
Completion date
2023-04-25
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Neoplasms, Quality of life, Young adults

Brief summary

The purpose of this study is to adapt a web-based platform to deliver a group intervention for young adult cancer survivors.

Detailed description

In the first part of this study, the investigators adapted a website to deliver an evidence-based intervention for improving HRQOL for young adult cancer survivors, and then conducted usability testing sessions with young adult cancer survivors to get feedback on the website. In the second part of the study, the investigators will conduct a single-arm pilot trial in which the website will be used to deliver the intervention via weekly group meetings with a trained facilitator over the course of 10 weeks.

Interventions

Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18-39 years at the time of participation 2. Diagnosed with a primary cancer between 18-39 years old 3. Finished cancer treatment with curative intent 1 month to 5 years prior to enrollment (except hormone therapy) 4. NED and no anticipated/scheduled anti-cancer treatments at the time of enrollment (except hormone therapy) 5. Able to speak and read English 6. Able and willing to give informed consent 7. Access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences (Part 2 only)

Exclusion criteria

1. Ongoing or future anti-cancer treatments (beyond hormone therapy) are scheduled or anticipated 2. Documented or observable psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis, active substance abuse) Vulnerable populations will not be included in this study.

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction with the eHealth intervention deliveryAt the end of the 10-week intervention, overall and weekly satisfaction scores will be compiledImmediately after the intervention and each week participants will report their satisfaction with the full program through a brief survey.
Acceptability of the eHealth intervention deliveryAt the end of the 10-week interventionImmediately after the intervention participants will report their satisfaction with the full program through a brief survey.

Secondary

MeasureTime frameDescription
Change in perceived cognitive function from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Cognitive Function Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate better perceived cognitive function.
Change in depression symptoms from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Cognitive Function Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate better perceived cognitive function.
Change in perceived emotional support from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Emotional Support Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate greater perceived emotional support.
Change in fatigue from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Fatigue Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate more fatigue.
Change in pain interference from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Pain Interference Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate more pain interference.
Change in health-related quality of life (HRQOL) from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the 27-item Functional Assessment of Cancer Therapy - General. Scores range from 0 to 108, with higher scores reflecting better quality of life.
Change in pain intensity from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Pain Intensity 1a. Scores range from 0 to 10, with higher scores indicating greater pain intensity.
Change in cancer-related distress from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the 22-item Impact of Event Scale-Revised. Scores range from 0 to 88, with higher scores indicating greater cancer-related distress.
Change in stress management self-efficacy skills from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete subscales from the Measure of Current Status. Subscale scores range from 0 to 8, 0 to 12, or 0 to 20 depending on the subscale. Higher scores indicate more of the construct being assessed.
Change in coping from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the Brief Coping Orientation to Problems Experienced scale, which yields 14 two-item subscales. Subscale scores range from 2 to 8, with higher scores indicating greater usage of the coping strategy being assessed.
Change in patient-reported physical function from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the PROMIS Physical Function Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate better patient-reported physical function.
Change in anxiety symptoms from baseline to immediately after the interventionBaseline and immediately after the interventionParticipants will complete the Patient-Reported Outcomes Measurement Information System (PROMIS) Emotion Distress-Anxiety Short Form 4a. Raw scores are converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores indicate more symptoms of anxiety.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026